16
report
Models for Biomedical Innovation and Commercialization
This report relates to a Financial Innovations Lab held in Jerusalem in 2015 that led to new work a
nd major collaborative projects between the Milken Innovation Center and universities in the U.S..
+ Read More
report
Innovative Financing for Global Health R&D
Because the eradication of diseases like tuberculosis and malaria would have a dramatic impact on e
merging economies, investors in these countries including multinational aid providers, foundations, corporations and institutional funds sought to work to
+ Read More
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Financing the Control of Tuberculosis
As of 2015, roughly one third of the world’s population, mostly in poorer countries, carried tuberc
ulosis bacteria in their system. Given the characteristics of airborne diseases like tuberculosis, coordination among national and international age
+ Read More
report
New Models for Financing Translational Medical Research in Singapore
Adapting scientific lab discoveries into life-saving drugs for commercial consumption is no small f
eat. Often times medical research stalls when drugs get to the translational stage of the process.
+ Read More
report
Financing Lung Cancer Screening in China
Lung cancer, one of the most preventable diseases, surpasses all other cancer deaths worldwide.
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More
article
Financial innovations can help produce new medicines through funding of early-stage drug development, Milken Institute report says
Despite the enormous potential of biomedical research to cure disease, public and private funding ha
s declined — a trend that could jeopardize efforts to find improved treatments for people with life-threatening illnesses.
+ Read More
article
Creating Markets for Medical Innovation with Lower Commercial Potential
The biopharmaceutical industry is in a period of transition.
article
New, effective investment models work to fund drug discovery for the developing worldMilken Institute report identifies innovative financing for global health research
LOS ANGELES— The world of medicine has long been divided— between developed countries that can affor
d cutting-edge treatments and developing ones whose poor populations too often go without urgently needed care.
+ Read More
article
Stories from the Field: Adriano Abbud
Please tell us what brought you to the Adolfo Lutz Institute’s Rapid Response Center.
When the CO
VID-19 pandemic erupted, our general director invited me to take on the Rapid Response Center, with the task of bringing produc
+ Read More
article
FasterCures Quarterly Update—January 2024
In This Newsletter
New FasterCures Team Members
Recent FasterCures Publications
Events and Convenin
gs Recap
+ Read More